S&P 500
5,940.46
-0.4%
-23.14
DJI
42,677.24
-0.3%
-114.83
NASDAQ
$19,142.71
-0.4%
-$72.75
Bitcoin
106,871.00
+1.1%
+1,187.95
AAPL
$206.73
-1.0%
-$2.05
AMZN
$204.08
-1.0%
-$2.08
GOOG
$165.14
-1.6%
-$2.73
META
$636.43
-0.6%
-$4.00
MSFT
$457.90
-0.2%
-$0.97
NVDA
$134.22
-1.0%
-$1.34
TSLA
$343.52
+0.4%
+$1.43
Clene (NASDAQ: CLNN)
$2.62
(-0.4%)
-$0.01
Price as of May 20, 2025, 3:46 p.m. ET
Clene Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Clene Company Info
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development of therapeutics for neurodegenerative diseases. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded on August 12, 2020 and is headquartered in Salt Lake City, UT.
News & Analysis
Featured Article
Why Shares of Clene Jumped 11.8% on Monday
The company's lead therapy has shown progress against ALS in preliminary trials.
Jim Halley | Jul 18, 2022
Featured Article
Why Clene Stock Skyrocketed Today
One Wall Street analyst has high hopes for the biopharmaceutical company.
Prosper Junior Bakiny | Feb 3, 2021
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.